Insulin, insulin-like growth factors and neoplasia
Open Access
- 31 August 2008
- journal article
- review article
- Published by Elsevier BV in Best Practice & Research Clinical Endocrinology & Metabolism
- Vol. 22 (4), 625-638
- https://doi.org/10.1016/j.beem.2008.08.004
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteinsJCI Insight, 2008
- Functionally significant insulin-like growth factor I receptor mutations in centenariansProceedings of the National Academy of Sciences of the United States of America, 2008
- Enhanced sensitivity to IGF-II signaling links loss of imprinting ofIGF2to increased cell proliferation and tumor riskProceedings of the National Academy of Sciences of the United States of America, 2007
- Quantitative Mass Spectrometry Identifies Insulin Signaling Targets in C. elegansScience, 2007
- Characterization of insulin/IGF hybrid receptors: contributions of the insulin receptor L2 and Fn1 domains and the alternatively spliced exon 11 sequence to ligand binding and receptor activationBiochemical Journal, 2007
- Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K/Akt pathway activation in glioblastoma and prostate cancerProceedings of the National Academy of Sciences of the United States of America, 2007
- Disrupting insulin-like growth factor signaling as a potential cancer therapyMolecular Cancer Therapeutics, 2007
- Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteinsProceedings of the National Academy of Sciences of the United States of America, 2006
- Insulin-like growth factors and neoplasiaNature Reviews Cancer, 2004
- Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysisThe Lancet, 2004